Arcadia Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Arcadia Biosciences

16/08/2021 22:37

* Arcadia Biosciences Inc  RKDA.OQ  reported a quarterly
adjusted loss of 24 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 27 cents per share.
* Revenue rose 400% to $1.41 million from a year ago;  analysts
expected $1.71 million. 
* Arcadia Biosciences Inc's reported EPS for the quarter was a
loss of 24 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Arcadia Biosciences Inc shares had fallen by 20.9% this
quarter and lost 7.1% so far this year.
* The company reported a quarterly loss of $5.26 million.
* Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $7.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 09:37 p.m.  ​All
figures in US dollars unless otherwise stated